Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse

This publication has 59 references indexed in Scilit:

• QUINOLINIC ACID AND KYNURENINE PATHWAY METABOLISM IN INFLAMMATORY AND NON-INFLAMMATORY NEUROLOGICAL DISEASE
  Brain, 1992
• Presence of 3‐Hydroxyanthranilic Acid in Rat Tissues and Evidence for Its Production from Anthranilic Acid in the Brain
  Journal of Neurochemistry, 1990
• Lymphocyte migration into brain modelled in vitro: Control by lymphocyte activation, cytokines, and antigen
  Cellular Immunology, 1990
• The Potential Role of Interferons and Interferon Antagonists in Inflammatory Disease
  Drugs, 1989
• Cerebrospinal fluid quinolinic acid concentrations are increased in acquired immune deficiency syndrome
  Annals of Neurology, 1989
• Prolonged exposure to submicromolar concentrations of quinolinic acid causes excitotoxic damage in organotypic cultures of rat corticostriatal system
  Neuroscience Letters, 1989
• (18O)quinolinic acid: Its esterification without back exchange for use as internal standard in the quantification of brain and CSF quinolinic acid
  Journal of Mass Spectrometry, 1988
• Systematic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone
  Life Sciences, 1988
• Human macrophages degrade tryptophan upon induction by interferon-gamma
  Life Sciences, 1987
• Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid
  Neuroscience Letters, 1984